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INTRODUCTION 
Hamartoma is a nodular malformation, with a single or multiple malformations, it is a recognized prenatal developmental 
abnormality. This benign tumor lesion has the same histological components of normal parenchyma, but these components are arranged 
haphazardly which disrupts normal function. Hamartomas usually remain connected with the tissue of origin; as is the case with pulmonary 
hamartoma or the splenic hamartoma. The exact incidence of retinal astrocytic hamartoma (RAH) is not well known, but it is estimated at one 
case per 100 000 births per year [1]. The astrocytic hamartoma is neuroglial tissue and produces astrocytes within the optic nerve, [2] and 
consequently is often appears within papillary region. 
 
Congenital hypertrophy of retinal pigment epithelium (CHRPE) is also a developmental anomaly occurring during differentiation of 
the retina from the ectoderm. This lesion can be observed in 1 - 4.4 % of the general population regardless of gender and age [3]. 
 
The difference between these congenital lesions is the site of differentiation; glial cells in AH, and retinal pigment epithelium in 
CHRPE. AH is more often observed in patients with tuberous sclerosis [4], and maybe a precursor to central nervous system hamartomas. CHRPE 
can be isolated to the retina or present with familial adenomatous polyposis (FAP), especially when CHRPE lesions are multiple, grouped and 
bilateral. The coexistence of these two lesions types in the same patient is rare [5], within this article, we present the case of a 25-year old 
female who presented with AH in the right eye and CHRPE in the left eye.  
 
CASE REPORT  
A previously healthy, 25 year old female, presented with a central scotoma in her right eye, 3 days later this scotoma resolved 
spontaneously. Visual acuity at presentation was 0.9 decimal scales in both eyes. Examination of the anterior segment in both eyes was normal.  
 
Right eye - RAH 
The fundus examination revealed in the right eye a juxta-papilllary lesion in the temporal area. The lesion was white-yellowish, semi-
translucent, non-calcified and mildly protruding into the vitreous (Fig. 1A and Fig. 1B). Optical coherence tomography (OCT) of the right eye 
lesion showed a nodular lesion extending from optic nerve temporally to perifoveal area, and was 2468 μm x 3015 μm x 1099 μm (horizontal 
diameter x vertical diameter x thickness) (Fig. 1C, Fig 1D). A continuous transition from an abnormal retina towards a normal retina was 
observed on OCT images (thicker, with posterior shadowing, with no “moth-eaten spaces”) (Fig. 2A). The outer plexiform layer showed distinct 
cystic spaces. Ultrasonography (US) of the right eye lesion showed a nodular hyper-reflective lesion with no posterior shadowing, nor intra-
tumor calcifications, and was useful to rule out a possible retinoma /retinoblastoma (Fig. 5B). OCT-RNFL (OCT-retinal nerve fiber layer) thickness 
showed an abnormal thickness in temporal fibers and was correlated to visual field defect (enlarged blind spot) detected on visual field 
examination with Octopus 30 degree (Fig. 6).  
At a later visit, Fluorescein angiography (FA) confirmed the vascularized nature of the lesion in the right eye (Fig. 3A 3B), another 
hyper fluorescent nodular lesion was detected superonasally in the juxta-papillary area, and that lesion was not previously identified on fundus 
examination (Fig.3C Fig.3D). This second lesion was also confirmed by OCT (Fig. 2B) and angio OCT (Fig. 2C). Indocyanine green angiography 
(ICGA) did not show hyper-cyanescence in later images (Fig.3). Blue auto-fluorescence (BAF) showed a masking effect at the location of the 
tumor lesion (Fig. 5A).  
 
Left eye - CHRPE  
In the left eye, fundus examination revealed in the temporal periphery a CHRPE, a hyper-pigmented, round, flat lesion surrounded by 
a hypo-pigmented halo (Fig. 1E and Fig. 1F). OCT of the CHRPE in the left eye showed atrophy of the outer retina with thinning of outer nuclear 
layer (Fig. 1G). Fluorescein angiography (FA) showed a peri-papillary leakage due to dilated juxta-papillary vessels within the lesion. 
The combination of clinical and imaging findings confirmed the diagnosis of juxtapapillary astrocytic hamartomas in the right eye and 
CHRPE in the left eye. A detailed clinical examination and imaging studies were done to rule out a possible tuberous sclerosis. The patient did 
not have any abnormal skin lesion (adenoma sebaceous, ash leaf spots or café-au-lait spots). Cardiac and pulmonary auscultation was normal. 
Brain MRI was normal and did not show any astrocytic nodule. The patient has no past medical history of epileptic seizure and no family history 
of phacomatosis, familial adenomatous polyposis or retinal tumors.  
 
DISCUSSION 
Lesions associated with RAH are often located outside the macula and remain asymptomatic; therefore detection is more likely to 
occur during routine fundus examination or during the workup of a patient with tuberous sclerosis. In the case reported here, the patient did 
not have any extra-ocular lesion, classically found in those with tuberous sclerosis. However, a secondary smaller RAH located in the superonasal 
juxtapapillary area (with confirmation on FA and OCT Fig. 2B, Fig. 3C, Fig. 3D) was observed close to the main temporally located astrocytic 
hamartoma. According to Roach et al. [6], the presence of this secondary lesion is a strong indication of the diagnosis of tuberous sclerosis. 
Moreover, the presence of a CHRPE in contralateral eye is also a minor indication of the diagnosis of tuberous sclerosis. Combined these criteria 
suggest the diagnosis of tuberous sclerosis in this patient, however as there was no extra-ocular involvement, the diagnosis was not confirmed, 
and we choose not to test for TSC1 and TSC2 mutations.  
In tuberous sclerosis, RAH has been associated with, unilateral or bilateral, decreased visual acuity, metamorphopsias or scotoma(e) 
especially in cases with macular edema[7]. Isolated retinal RAH is usually asymptomatic [8]. In this case, the patient had a central scotoma in her 
right eye (Fig. 6), however this later resolved. In a study by Schields et al [9] in 15 cases of RAH, retinal alterations were observed in all retinal 
layers except outer retina (from ONL to RPE). In the present case, OCT revealed the presence of microcystic changes in outer plexiform layer in 
perimacular area (Fig. 2A).  
Juxta-papillary highly vascularized RAH have been associated with self-limited episodes of exudation, with transitory symptomatic 
discomfort, as was case in the patient described herein who complained of central scotoma lasting 3-days. Microcystic changes in outer 
plexiform layer can occur with episodes of exudation. In general, when RAH presents in isolation it is not associated with exudation, which is in 
contrast with RAH presenting with concomitant tuberous sclerosis has been associated with exudative retinal detachment in extreme cases [10]. 
A through exam should include several imaging modalities including fluorescein angiography, as many retinal lesions may go 
undiagnosed with simple fundus examination. Patients elevated risk of tuberous sclerosis be seen more frequently. For example the case 
presented here, since the symptoms were transitory and since there is no treatment for RAH, this patients is being observed on an annual basis 
with a combination of clinical and imaging examination. To the best of our knowledge this is the second case of the RAH and CHRPE 
simultaneously presenting in contralateral eyes [5]. This combination could be a part of the larger tuberous sclerosis syndrome. 
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Fig. 1 
 
Fig. 1A Optos Photo of fundus of right eye showing an astrocytic hamartoma  in the temporal juxtapapillary area. The astrocytic hamartoma 
appears as a white yellowish, poorly delimitated lesion protruding toward the vitreous, with poorly visible cilioretinal artery within the tumour. 
Lipid exudations could also be seen in macular area. Fig. 1B Topcon Photo of the fundus of the right eye. Fig. 1C OCT images of the right optic 
nerve showing the astrocytic hamartoma. Fig. 1D ICG angioagraphy at 30 minutes showing the astrocytic hamartoma as a hypocyanescent 
lesion. Fig. 1E Optos Photo of the fundus of the left eye showing the CHRPE in the temporal periphery. Fig. 1F Topcon Photo of the fundus of the 
left eye showing the CHRPE in the temporal periphery: hyperpigmented lesion of 2 disc diameters, surrounded by a clear hypopigmented halo. 
Fig. 1G OCT image centered at the CHRPE showing retinal thinning at the level of outer nuclear layer.   
Fig. 2 
 
 
Fig. 2A OCT of the astrocytic hamartoma showing microcystic changes at the level of the outer plexiform layer. Fig. 2B OCT of the optic nerve in 
the right eye showing the second astrocytic hamartoma located superonasally, which was not seen on fundus examination. Fig. 2C Angio OCT 
compatible with a vascularized lesion in the ganglion cell layer 
 
 
Fig. 3 
 
Fig. 3A, 3B, 3C, 3D Fluorescin angiography showing highly vascularised tumoral lesion in the temporal juxtapapillary area at different times 
respectively: 13 seconds, 18 seconds, 2 minutes and 11 minutes. Fig 3C and Fig. 3D show also the second astrocytic hamartoma (white arrow). 
 
 
 
 
 
 
 
Fig. 4 
 
Fig. 4A, 4B, 4C, 4D Indocyanine green angiography of the right eye showing the retinal astrocytic hamartoma at different time (13 seconds, 18 
seconds, 2 minutes and 30 minutes, respectively)  
 
 
 
 
 
Fig. 5 
 
Fig. 5A Blue Autofluorescence of the right eye (30 degree) showing a hypoautofluorescent lesion in the region of the astrocytic hamartoma 
related to the presence of a richly vascularised network within the tumor.  
Fig. 5B Ultrasonography of the right eye showing the astrocytic hamartoma as a hyperreflective lesion with a localized thickening of the retina 
but with no posterior shadowing. 
 
 
 
Fig. 6 
 
Fig. 6 Visual field (octopus 30 degree) showing an enlargement of the blind spot in the right eye. 
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